Bronchoscopes Market Size, Share & Industry Analysis, By Product Type (Flexible Bronchoscopes, Rigid Bronchoscopes, and Disposable Bronchoscopes), By Usability (Reusable Bronchoscopes and Single-Use Bronchoscopes), By Patient Type (Adult and Pediatric), By End-user (Hospitals & ASCs, Specialty Clinics, and Others), and Regional Forecast, 2026-2034

The global bronchoscopes market size was valued at USD 782.9 million in 2025. The market is projected to grow from USD 839.3 million in 2026 to USD 1,544.8 million by 2034, exhibiting a CAGR of 7.9% during the forecast period. North America dominated the bronchoscopes market with a market share of 31.86% in 2025.

Bronchoscopes are medical devices used by healthcare professionals to inspect the airways and lungs. They help diagnose and treat conditions such as infections, tumors, blockages, and breathing problems. The device is inserted through the mouth or nose and allows doctors to view the inside of the lungs with a small camera. The market growth is attributed to the rising prevalence of respiratory diseases, an aging population, increased smoking, air pollution, and the growing incidence of respiratory infections. In addition, technological advancements, coupled with rising demand for cutting-edge innovations, are expected to propel market growth.

• For instance, in September 2025, Olympus Corporation announced the launch of its new Endobronchial Ultrasound (EBUS) bronchoscope in Europe, the Middle East, and Africa.

Furthermore, many key industry players, such as Olympus Corporation, Ambu A/S, Boston Scientific Corporation, FUJIFILM Holdings Corporation, and HOYA Corporation, operating in the market, are focusing on developing innovative technologies to offer better products with improved accuracy and efficiency.

Download Free sample to learn more about this report.

BRONCHOSCOPES MARKET TRENDS

Growing Use of Bronchoscopes in Intensive Care Units is a Key Market Trend

The market is witnessing an increase in the adoption of bronchoscopes in intensive care units for critically ill patients. Doctors use them to clear airway blockages, remove secretions, and assist with breathing support procedures. Moreover, many ICU patients require quick and safe airway management, thereby increasing the need for bronchoscopic procedures. Further, single-use bronchoscopes are especially preferred in these settings as they are ready to use and reduce infection risks.

• For instance, in August 2021, Boston Scientific Corporation received FDA approval for its single-use bronchoscope, EXALT. The product is specifically designed for utilization in ICU and operating rooms.

MARKET DYNAMICS

MARKET DRIVERS

Download Free sample to learn more about this report.

Rising Prevalence of Respiratory Conditions Across the Globe to Propel Market Growth

Rising prevalence of respiratory diseases such as lung infections, Chronic Obstructive Pulmonary Disease (COPD), and lung cancer is prominently accelerating the global bronchoscopes market growth. In addition, aging populations, smoking habits, and air pollution are also expected to propel market growth during the forecast period.

• For instance, according to a data published by the Centers for Disease Control and Prevention, an estimated 14.2 million people in the U.S. were diagnosed with COPD in 2021.

MARKET RESTRAINTS

High Cost of Advanced Bronchoscopes to Deter Market Growth

Advanced bronchoscopes, especially video and disposable models, can be expensive for some hospitals. Smaller healthcare facilities may find it difficult to invest in large numbers of these devices. Moreover, reusable bronchoscopes also require cleaning, maintenance, and trained staff, which adds to overall costs. Budget limitations in developing regions may slow the adoption of newer technologies. These cost-related factors can restrain market growth in certain areas.

MARKET OPPORTUNITIES

Growing Demand for Infection-Control Solutions to Offer Lucrative Market Growth Opportunities

Healthcare facilities are emphasizing infection prevention due to strict government and healthcare regulations. Reusable bronchoscopes require thorough cleaning, and any mistake can increase infection risk. In addition, disposable bronchoscopes solve this problem as they are used once and then discarded. This reduces cross-contamination and simplifies workflow. As hospitals adopt stricter infection-control practices, demand for single-use bronchoscopes is increasing. This creates strong growth opportunities for manufacturers offering disposable solutions.

MARKET CHALLENGES

Limited Reimbursement for Bronchoscopy Procedures to Pose a Critical Challenge to Market Growth

In some regions, reimbursement for bronchoscopy procedures and related devices is limited or varies between healthcare systems. Moreover, hospitals may not receive full payment for using advanced or disposable bronchoscopes, which can affect purchasing decisions. This is especially challenging for smaller hospitals and clinics operating on tight budgets. When reimbursement is uncertain, healthcare providers may continue using older or reusable equipment instead of switching to newer single-use devices. Differences in reimbursement policies across countries also create uneven adoption rates.

Segmentation Analysis

By Product Type

Emphasis on Infection Reduction is Projected to Boost Disposable Bronchoscopes Segment Growth

Based on the product type, the market is divided into flexible bronchoscopes, rigid bronchoscopes, and disposable bronchoscopes.

The disposable bronchoscopes segment is anticipated to account for the largest bronchoscopes market share. Growing emphasis on infection prevention and reduction is projected to accelerate segment growth during the forecast period. In addition, these devices are used once and then discarded, eliminating the need for cleaning and sterilization. This saves time, reduces maintenance costs, and improves patient safety. Further, the growing number of product approvals and launches is expected to leverage segment growth.  

• For instance, in April 2023, Verathon announced launch of its new single-use bronchoscope. The new device is compatible for adult as well as pediatric procedures.

The flexible bronchoscopes segment is anticipated to rise with a CAGR of 7.4% over the forecast period.  

To know how our report can help streamline your business, Speak to Analyst

By Usability

Substantial Convenience Offered by Single-Use Bronchoscope to Propel Segment Growth

Based on usability, the market is segmented into reusable bronchoscopes and single-use bronchoscopes.

In 2025, the single-use bronchoscopes segment dominated the global market. Single-use bronchoscopes dominate this segment as they are convenient and safe. Moreover, hospitals can use them immediately without waiting for sterilization. This helps speed up procedures and improve efficiency. Single-use devices also reduce the risk of cross-contamination between patients.

The reusable bronchoscopes segment is anticipated to rise with a CAGR of 7.1% over the forecast period.

By Patient Type

High Occurrence of Respiratory Conditions in Adult Patients to Boost Adult Segment Growth

Based on patient type, the market is segmented into adult and pediatric.

In 2025, the adult segment dominated the global market. The adult segment growth is attributed to the higher prevalence of respiratory conditions amongst adults. Moreover, conditions such as COPD, lung cancer, and chronic infections occur more frequently in adults than in children. As the global population ages, the number of adult patients requiring bronchoscopy procedures continues to grow.

The pediatric segment is anticipated to rise with a CAGR of 5.2% over the forecast period.

By End-User

Higher Volume of Bronchoscopy Procedures in Hospitals & ASCs to Accelerate Segment Growth

Based on end-user, the market is segmented into hospitals & ASCs, specialty clinics, and others.

In 2025, the hospitals & ASCs segment held the highest market share. Hospitals and ambulatory surgery centers dominate the market as most bronchoscopy procedures are performed in these settings. These facilities have the equipment, trained staff, and infrastructure required for respiratory procedures. Hospitals also care for a greater number of critically ill patients who may require bronchoscopy. Furthermore, the segment is set to hold an 83.0% share in 2026.

In addition, specialty clinics segment is projected to grow at a CAGR of 9.3% during the forecast period.

Bronchoscopes Market Regional Outlook

By geography, the market is categorized into Europe, North America, Asia Pacific, Latin America, and the Middle East & Africa.

North America

To get more information on the regional analysis of this market, Download Free sample

North America held the dominant share in 2024, valued at USD 233.6 million, and also maintained the leading share in 2025, with USD 249.5 million. The market in North America is expected to increase due to the higher prevalence of respiratory conditions and new product launches.

U.S. Bronchoscopes Market

Based on North America’s strong contribution and the U.S. dominance within the region, the U.S. market is set to reach around USD 227.5 million in 2026, accounting for roughly 27.1% of global sales.

Europe

Europe is projected to record a growth rate of 7.3% in the coming years, and reach a valuation of USD 226.2 million by 2026. The region is estimated to witness considerable market growth due to an increasing number of product approvals and technological developments.

U.K. Bronchoscopes Market

The U.K. market in 2026 is estimated at around USD 36.7 million, representing roughly 4.4% of global revenues.

Germany Bronchoscopes Market

Germany’s market is projected to reach around USD 50.9 million in 2026, equivalent to around 6.1% of global sales.

Asia Pacific

Asia Pacific is estimated to reach USD 258.4 million in 2026 and secure the position of the second-largest region in the market. Aging population and rising incidence of COPD is projected to accelerate regional growth.

Japan Bronchoscopes Market

The Japan market in 2026 is estimated at around USD 44.8 million, accounting for roughly 5.3% of global revenues.

China Bronchoscopes Market

China’s market is projected to be one of the largest worldwide, with 2026 revenues estimated at around USD 85.8 million, representing roughly 10.2% of global sales.

India Bronchoscopes Market

The Indian market in 2026 is set to reach USD 57.3 million, accounting for roughly 6.8% of global revenues.

Latin America and the Middle East & Africa

The Latin America and the Middle East & Africa regions are likely to experience moderate growth in this market over the forecast period. The Latin America market is expected to reach a valuation of USD 53.2 million in 2026. In the Middle East & Africa, the GCC market is anticipated to reach a value of USD 12.9 million in 2026.

South Africa Bronchoscopes Market

The South Africa market is projected to reach around USD 5.3 million in 2026, representing roughly 0.63% of global revenues.

COMPETITIVE LANDSCAPE

Key Industry Players

Growing Number of Product Launches and Rising Number of Collaborations by Key Players to Boost Market Progress

The global bronchoscopes market holds a semi-consolidated market structure, including key players such as Olympus Corporation, Ambu A/S, Boston Scientific Corporation, FUJIFILM Holdings Corporation, and HOYA Corporation. The significant global market share of these companies is driven by several strategic activities, including distribution collaborations and implementation of new programs.

• For instance, in July 2022, Ambu received FDA approval for its 5^th-generation single-use bronchoscope.

Other notable players in the global market are KARL STORZ SE & Co. KG, Richard Wolf GmbH, Medtronic plc, Micro-Tech Co., Ltd., and Zhuhai Seesheen Medical Technology Co., Ltd. These companies are likely to prioritize collaborations to increase their global market share over the forecast period.

LIST OF KEY BRONCHOSCOPES COMPANIES PROFILED

• Olympus Corporation (Japan)
• Ambu A/S (Denmark)
• Boston Scientific Corporation (U.S.)
• FUJIFILM Holdings Corporation (Japan)
• HOYA Corporation (Japan)
• KARL STORZ SE & Co. KG (Germany)
• Richard Wolf GmbH (Germany)
• Medtronic plc (Ireland)
• Micro-Tech (Nanjing) Co., Ltd. (China)
• Zhuhai Seesheen Medical Technology Co., Ltd. (China)
• EndoFresh Medical Co., Ltd. (China)    

KEY INDUSTRY DEVELOPMENTS

• February 2026: FUJIFILM Healthcare Europe entered into a strategic collaboration with Lys Medical for expansion of its bronchoscope product portfolio.
• January 2026: FUJIFILM Healthcare Europe announced introduction of flexible ultrasound bronchoscope for detection of lung cancer.
• May 2024: Olympus Corporation announced launch of new bronchoscopes which are compatible with EVIS X1 endoscopy system.
• November 2022: Fujifilm announced expansion of its pulmonology portfolio in India. This step will help the company to consolidate its presence in India.    
• May 2021: PENTAX Medical announced introduction of its new bronchoscope, ONE Pulmo in Europe market.

REPORT COVERAGE

The global bronchoscopes market analysis includes a comprehensive study of the market size and forecast for all the market segments included in the report. It includes details on the market dynamics and trends expected to drive the market over the forecast period. It provides information on key aspects, including an overview of technological advancements, the regulatory environment, and product launches. Additionally, it details partnerships, mergers, and acquisitions, as well as key industry developments and investments by key regions. The global market research report also provides a depth competitive landscape with information on the market share and profiles of key operating players.

Request for Customization   to gain extensive market insights.

Report Scope & Segmentation